Gustave Roussy — Paris

Public research footprint of Gustave Roussy, compiled from the ClinicalTrials.gov public registry.

1,097

Registered studies

438

Active

245

Recruiting now

483

Completed

111

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Metastatic/Locally Advanced Non-Small-Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gustave Roussy?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.